We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The β-glucosidase assay: a new diagnostic tool for necrotizing enterocolitis. Sensitivity, specificity, and predictive values.
- Authors
Gómez-Chaparro Moreno, José; Rodríguez Torronteras, Alejandro; Ruiz González, María; Izquierdo Palomares, Lucía; Bonilla Valverde, Daniel; Ruiz Laguna, Julia; Delgado Rubio, Alfonso; López-Barea, Juan; Gómez-Chaparro Moreno, José Luis; Rodríguez Torronteras, Alejandro; Ruiz González, María Dolores; Izquierdo Palomares, Lucía; López-Barea, Juan
- Abstract
<bold>Unlabelled: </bold>We aimed to establish the utility of serum cytosolic β-glycosidase (CBG) assay as a NEC diagnosis tool. CBG activity has been compared in 192 NEC-free (NEC(-)) and 13 NEC-affected (NEC(+)) neonates, with modified Bell's stages II/III, born at Reina Sofia University Hospital; additional blood hematology, microbiology, and biochemical parameters have been assayed. NEC(+) neonates have higher serum CBG activity, 26.4 ± 12.4 mU/mg; 95 % CI (18.8-33.9), than NEC(-) infants, 11.0 ± 6.6 mU/mg; 95 % CI (10.1-11.9) (p < 0.0001). The CBG cutoff value in the ROC curve, 15.6 mU/mg, discriminates NEC(+)/NEC(-) infants with 84.6 % sensitivity, 85.9 % specificity, 37.9 positive predictive value and 98.2 negative predictive value, 6.11 positive likelihood ratio and 0.18 negative likelihood ratio, 33.61 DOR, and 0.89 AUC. A combined panel [CBG + aspartate aminotransferase + C-reactive protein] shows a 0.90 AUC value in multiple linear regressions.<bold>Conclusions: </bold>The serum CBG level is a good NEC diagnosis test and a novel NEC biomarker which may become a screening tool.<bold>What Is Known: </bold>•NEC affects ∼2.5 % of infants at NICU, ∼90 % of them weighing <1500 g. •NEC requires a careful differential diagnosis, being lethal if not diagnosed and treated. What is new: •CBG assay will be useful to determine infants without NEC and preventing unnecessary treatment. •CBG assay could discriminate NEC better than other gut-specific sera protein biomarkers.
- Subjects
GLUCOSIDASES; NEONATAL necrotizing enterocolitis; HEMATOLOGY; BIOMARKERS; REGRESSION analysis
- Publication
European Journal of Pediatrics, 2016, Vol 175, Issue 7, p931
- ISSN
0340-6199
- Publication type
journal article
- DOI
10.1007/s00431-016-2724-8